Interventional Oncology Therapies and the TME by American Roentgen Ray Society (ARRS)

Interventional Oncology Therapies and the TME is organized by American Roentgen Ray Society (ARRS).

Date of issuance: February 22, 2018
Date of expiration: February 21, 2021

Accreditation:
The ARRS designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Statement of Need:
AJR articles fulfill educational needs at all practice levels by addressing new research and studies, reviewing standards of care and addressing clinical practice and educational needs. Needs sources for the AJR include clinical practice guidelines, peer-reviewed literature, and expert defined needs.

Objectives:
After completing the material in this article, the learner should be able to:
• Recognize the unique characteristics of the tumor microenvironment (TME);
• Recognize the role embolotherapy and ablative therapies have in altering the TME; and
• Identify strategies to optimize and enhance the efficacy of interventional oncology therapies.